Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
about
MRI reveals differential effects of amphetamine exposure on neuroglia in vivoStrategies for treatment in Alexander diseaseAlexander diseaseGFAP and its role in Alexander diseaseAstrocytes: the missing link in neurologic disease?Astrocytes are central in the pathomechanisms of vanishing white matterAstrocytes: biology and pathologyInfantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation.Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survivalAstrocyte heterogeneity in the brain: from development to diseaseOvercoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic miceAlteration of glial-neuronal metabolic interactions in a mouse model of Alexander diseaseCeftriaxone for Alexander's Disease: A Four-Year Follow-Up.The origin of Rosenthal fibers and their contributions to astrocyte pathology in Alexander diseaseAdult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literatureAstrocytic TDP-43 pathology in Alexander diseaseCharacterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP.Astrocyte heterogeneity across the brain and spinal cord occurs developmentally, in adulthood and in response to demyelination.Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways.Proliferative reactive gliosis is compatible with glial metabolic support and neuronal function.Involvement of p300 in constitutive and HIV-1 Tat-activated expression of glial fibrillary acidic protein in astrocytes.Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease.Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response.Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease modelAstrogliosis.Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease.Formation of GFAP cytoplasmic inclusions in astrocytes and their disaggregation by alphaB-crystallin.The impact of glial activation in the aging brainNeurological diseases as primary gliopathies: a reassessment of neurocentrismElevated GFAP induces astrocyte dysfunction in caudal brain regions: A potential mechanism for hindbrain involved symptoms in type II Alexander disease.CSF and Blood Levels of GFAP in Alexander DiseaseProtection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic proteinNitric oxide mediates glial-induced neurodegeneration in Alexander diseaseAllele-specific nuclear positioning of the monoallelically expressed astrocyte marker GFAPAn In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease.Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometryArchetypal and new families with Alexander disease and novel mutations in GFAP.GFAP expression as an indicator of disease severity in mouse models of Alexander disease.A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain
P2860
Q22065963-CDF68151-2779-4750-BC20-0CC9715509B0Q24596794-B849955F-5BEF-4DF3-A596-924D5C43C9D3Q24633313-B6482D9D-53F9-4687-BDE8-785CAB3E0668Q24657223-25CB6705-1A3E-464D-8E19-AE5CCD454005Q26861132-3529BD8F-519B-4553-BEDC-9AE251F90631Q27330146-A5C8AF25-B1D1-4DCC-B9D2-9890CD2DFD3EQ27490746-0DB576E7-E409-459B-8C57-2C31EDBBEFB4Q28359825-E39C74EF-D65A-47E5-BFEB-92D41BB070D5Q28385079-1D0F24F8-9613-4741-BA81-3AAD06D24F77Q28390187-35E80C4F-A0BB-4BD8-851D-FE2E03368E2BQ28590085-BE1719E3-9985-45E0-A1B1-F11BFA6518E6Q28750231-A4B5E97A-8F92-4F45-809A-8814E68A04C5Q30534666-6A912537-6AAE-41F9-911E-A5CE82821669Q30843456-CB380959-B7B0-46C3-BB32-C153A78D341DQ33548488-CE4CA765-CF29-47E3-8E5F-E0F962D885BAQ33575134-35996041-E2D1-4C23-A12C-514E6EF7AABDQ33888244-7D33D1F8-7835-46E0-8FE5-8C68721E8DABQ33897709-D8394E75-2E60-412E-97EA-FA4C1ADC9167Q33985888-02EF5EB5-2D9A-4B74-97DE-F944A2EF1170Q34045171-114B11E6-D256-40AA-B6D9-18B0699A87ECQ34057814-858A6A47-5D74-474B-B8FF-15BE74B6736BQ34183917-DA4B940E-C0BB-4CCB-A6F8-356AFC037C11Q34194556-60EC4542-7B3C-4649-B7D0-2695627920B4Q34200416-52F72100-FC36-45D2-AA3B-2462AE226494Q34857360-F41D1151-DC19-49E6-BDDE-566B7FB5A1FBQ35045104-85098BE4-8007-4176-9019-B39122D6B2E6Q35778386-062B7EFC-AD9E-4AFF-823C-8D9F4590ABBEQ35786986-7792427F-74F7-4A8D-BCBC-7BB1B0800B60Q35806715-95D7DA20-D414-4BBD-9147-B6BD9F010682Q35872654-20ED5FD3-32AF-437E-B5E1-91DB9E0C5CBAQ36014767-B2A31269-AFE2-4E3C-917D-25093BB3BC44Q36154360-7A845B14-5600-4767-9D50-A2C31DECBD55Q36202870-97D4C155-D587-41B6-9719-18DB9FDC087AQ36360991-1F14FC81-02E9-4A17-9CBF-F218F1B8C86FQ36453549-34FA2947-8AED-493D-8EF0-C69B77470748Q36534299-82C73BBC-5148-4109-817F-82169CC60C13Q36599253-D1860767-73E6-404A-BAE3-17C43376495FQ36615888-8D40BCB5-310A-486C-BC8A-A7D3DF91AB0BQ36706156-AF053C84-0514-440E-A88E-5A63D2A84E87Q36832590-AF38DEA2-EE7D-4BE0-B015-83BF38616616
P2860
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@ast
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@en
type
label
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@ast
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@en
prefLabel
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@ast
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@en
P2093
P2860
P1476
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice
@en
P2093
E J Galbreath
J E Goldman
P2860
P304
P407
P50
P577
1998-02-01T00:00:00Z